# FDA Inspection 1001456 - Department of the Air Force - February 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/department-of-the-air-force/80af88a6-e6f1-4f2c-b135-fbbf50569dcb
Source feed: FDA_Inspections

> FDA Inspection 1001456 for Department of the Air Force on February 15, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1001456
- Company Name: Department of the Air Force
- Inspection Date: 2017-02-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 902229 - 2014-10-30](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force/8bd86113-2ee8-41c4-92aa-cb379dc54c02)
- [FDA Inspection 833439 - 2013-05-29](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force/d33a1671-768e-4600-af07-e7aae3faeb76)
- [FDA Inspection 732569 - 2011-06-16](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force/34de7d83-de51-4904-b6b6-b7fa5e1004c4)
- [FDA Inspection 552392 - 2008-12-04](https://www.keypedia.com/records/fda_inspections/department-of-the-air-force/10253c40-1425-48d8-b7c0-c17a5a6202ae)

Company: https://www.keypedia.com/companies/department-of-the-air-force/da1be0bd-d0b1-464f-959f-ce19e21ea3a4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d